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Development, validation, and utilization of a competitive
enzyme-linked immunosorbent assay for the detection of antibodies
against Brucella species in marine mammals
Jenny Meegan,1 Cara Field, Inga Sidor, Tracy Romano, Sandra Casinghino, Cynthia R. Smith,
Lizabeth Kashinsky, Patricia A. Fair, Gregory Bossart, Randall Wells, J. Lawrence Dunn
Abstract. A competitive enzyme-linked immunosorbent assay (cELISA) was developed by using a whole-
cell antigen from a marine Brucella sp. isolated from a harbor seal (Phoca vitulina). The assay was designed to
screen sera from multiple marine mammal species for the presence of antibodies against marine-origin
Brucella. Based on comparisons with culture-confirmed cases, specificity and sensitivity for cetacean samples
tested were 73% and 100%, respectively. For pinniped samples, specificity and sensitivity values were 77% and
67%, respectively. Hawaiian monk seal (Monachus schauinslandi; n 5 28) and bottlenose dolphin (Tursiops
truncatus; n5 48) serum samples were tested, and the results were compared with several other assays designed
to detect Brucella abortus antibodies. The comparison testing revealed the marine-origin cELISA to be more
sensitive than the B. abortus tests by the detection of additional positive serum samples. The newly developed
cELISA is an effective serologic method for detection of the presence of antibodies against marine-origin
Brucella sp. in marine mammals.
Key words: Brucella; competitive enzyme-linked immunosorbent assay; marine mammals; validation.
Introduction
Brucella sp. isolations in marine mammals were
first reported in 1994, and since then there have been
numerous reports of isolates from many marine
species.8,10,11,15,21,22,29,31,34 Classically, there are 6 rec-
ognized Brucella spp. that infect terrestrial mam-
mals.23,37 The Brucella biovars isolated from marine
mammals have microbiologic growth and genetic
characteristics distinct from the classically recognized
terrestrial species.2,8,10,17,20,22,29,32,37 Genetic analyses of
the various isolates from marine mammals indicate
diversity from the terrestrial species, and there is
strong evidence that shows that at least 2, if not more,
species or biovars exist in marine mammals. New
nomenclature for these marine species has been
proposed but not officially accepted.2,8,12,14,20,38
Serology is an effective and efficient tool for
screening animals for the presence of antibodies
against Brucella spp., which indicate a current active
infection or previous exposure. Multiple studies have
detected anti-Brucella antibodies in marine mammals
worldwide, from pinniped, cetacean, and mustelid
families.9,18,20,26,27,31–33 Traditionally, a variety of
serologic tests specifically designed and validated for
Brucella abortus have been used to screen marine
mammal sera for the presence of antibodies against
the bacterium. Both the specificity and sensitivity of
these tests for use with bovine serum are high;
however, results of testing in marine mammals are
often inconsistent, and comparisons between tests are
difficult to make.21,26 A consensus for determining a
positive result often requires that a marine mammal
serum sample must test positive on multiple tests.7
Although B. abortus antigen reacts with serum
from marine mammals infected with Brucella spp., it
is likely that a serologic test that uses antigen from a
marine mammal isolate may be more sensitive. Both
primary (lipopolysaccharide [LPS]) and secondary
(protein) antigenic determinants may be sufficiently
different to affect antigen–antibody affinity among
clades of bacteria.1 Use of a whole-cell antigen versus
specific cell wall components may also increase
sensitivity by allowing antibody binding to different
antigenic epitopes. Recently developed assays for
testing marine mammal serum have been briefly
described, including both indirect and competitive
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enzyme-linked immunosorbent assay (ELISA) test
methods16 (Miller WG, Romano TR, Pugh R, et al.:
2001, ELISA for detection of brucellosis in bottlenose
dolphins (Tursiops truncatus). In: Proceedings of the
32nd Annual Conference of the International Asso-
ciation of Aquatic Animal Medicine, pp. 142–143.
Tampa, FL; Estepp JD, Middlebrooks BL, Patterson
RA: 2005, Development of an immunodiagnostic
assay for Brucella sp. in the harp seal (Phoca
groenlandica) and hooded seal (Cystophora cristata).
In: Proceedings of the 36th Annual Conference of the
International Association of Aquatic Animal Medi-
cine, p. 97. Seward, AK). The antigens used in these
recently developed assays range from cell surface LPS
to whole-cell antigen.
The present report describes the development of a
cELISA by using whole-cell antigen from a harbor
seal (Phoca vitulina) marine Brucella sp. isolate, as
well as studies that validate and use the cELISA for
testing of marine mammal sera. Because this cELISA
measures competitive binding of known positive goat
serum and test sera to a common antigen via anti-
goat antibody secondary labeling, it alleviates the
need for numerous species-specific secondary anti-
bodies, as in indirect ELISA tests, and reduces time
and expense for production and testing.
Materials and methods
The cELISA developed in the current study was modified
from a previous protocol developed by collaborators at the
University of Southern Mississippi (Estepp JD, et al.: 2005,
Development of an immunodiagnostic assay for Brucella
sp. in the harp seal [Phoca groenlandica] and hooded seal
[Cystophora cristata]).
Antigen
A methanol-killed, whole-cell suspension of marine
Brucella isolated from a harbor seal (case no. 04-0281,
accession no. 311585) was obtained from the National
Veterinary Services Laboratory in Ames, Iowa. The
suspension was washed at 18,000 rcf for 10 min to remove
methanol, and cells were resuspended in sterile 13
phosphate buffered saline solution (PBS).a The final stock
of antigen was stored in aliquots at 220uC.
DNA was extracted from aliquots of bacterial suspen-
sions by using spin columns and the Gram-negative
bacteria protocol of a commercial DNA purification kit.b
The polymerase chain reaction assays performed on this
extract were positive for insertions of IS711 elements
previously described as specific for marine mammal strains
of Brucella.2,4 Typing of outer membrane protein sequences
showed this isolate to be within a subcluster of Brucella
pinnipedialis.6
Control sera
The positive control serum was obtained through
polyclonal antibody production in collaboration with
Rockland Immunochemicals.c Briefly, after performing a
direct ELISA to confirm the absence of antibodies against
Brucella antigens, a female Toggenburg goat (OLAW
assurance no. A4062-01), that weighed approximately
25 kg, was immunized with the previously described
methanol-killed, whole-cell marine Brucella antigen. The
immunization protocol included an initial injection of
400 mg, followed by 2 subsequent booster injections of
200 mg each at 1-week intervals, and a final injection
of 200 mg at a 2-week interval. Several direct ELISAs were
performedc during the project to confirm the development
of antibodies against the antigen and to measure serial titer
levels. Once an acceptable titer was detected, 120 ml of
serum and 1,050 ml of plasma were collected for use in the
assay development and as a positive control sample. Goat
serum and plasma antibody titers were compared, and no
difference was found between the 2 blood components;
therefore, plasma was collected, stored, and used because of
a larger collection volume. The negative control used for
the cELISA was goat plasma obtained from a goat that was
never immunized or exposed to Brucella.c
Secondary antibody
Immunoglobulin G (IgG) purification of the previously
described goat anti-Brucella plasma was performed by
Rockland Immunochemicals.c Briefly, the antibody was
purified from monospecific antiserum by a multistep process,
which includes delipidation and defibrination of the plasma,
followed by salt fractionation and ion exchange chromatog-
raphy. The purified antibody was then dialyzed extensively
against 0.02 M potassium phosphate and 0.15 M sodium
chloride, pH 7.2 with 0.01% (w/v) sodium azide. The purified
goat IgG was then biotinylated by using a commercial kit.d
Excess biotin was removed by dialysis.e The final biotinylated
IgG protein solution was stored at 220uC.
Competitive ELISA
Antigen coating was performed by diluting the whole-cell
marine Brucella antigen in coating buffer (Na2CO3 0.015 M,
NaHCO3 0.0348 M, NaN3 0.003076 M, pH 9.6, 1 liter) to
an optical density (OD) at 600 nm of 0.1 (1 3 109 cells/ml).
A 96-well microtiter ELISA platef was coated with 50 ml of
antigen solution per well, covered, and allowed to incubate
overnight at room temperature (22–25uC) for a minimum
of 12 hr and no longer than 18 hr. Two controls were
included on each plate: 1) a no-serum control (all steps
apply with the exception of the test serum), and 2) a blank
control (wells received coating buffer only during each step,
with the exception of the color-developing reagent at the
final step). Before each step, plates were washed 3 times by
using a wash buffer (Na2HPO4 0.04818 M, KH2PO4
0.008818 M, NaCl 0.8213 M, KCl 0.01609 M, NaN3
0.018458 M, Tween 20 3.00 ml, pH 7.4, 6 liters) on an
automated plate washer.g A 2% blocking buffer with
bovine serum albuminh was prepared by dilution in coating
of buffer, and 50 ml was added to each well. The plate then
was incubated for 30 min at 37uC followed by a wash step.
A 1:10 dilution of test sera and positive and negative
controls were prepared in incubation buffer (0.03 M
ELISA development and validation for marine-origin Brucella 857
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Na2HPO4, 0.02998 M KH2PO4, 0.41065 M NaCl 24.0,
1.50 ml Tween-20, pH 7.0, 3 liters). Fifty microliters of the
diluted sera were added to antigen-coated wells. All serum
samples and controls were tested in triplicate. The plate was
covered and allowed to incubate for 30 min at 37uC
followed by a wash step.
A 1:9000 dilution of the secondary biotinylated goat anti-
Brucella antibody IgG was prepared in incubation buffer,
and 50 ml was added to designated wells. The plate was
covered and allowed to incubate for 30 min at 37uC
followed by a wash step. A 1:30,000 dilution of the enzyme
substrate ExtraAvidin-labeled alkaline phosphatasei was
prepared in incubation buffer and 50 ml added to each
designated well. The plate was covered and allowed to
incubate for 30 min at 37uC followed by a wash step.
The color-developing reagent was prepared by using a
13 concentration solution of diethanolamine substrate
buffer 53j and diluted in NANOpure water. A developing
solution was then prepared by dissolving two 5-mg tablets
of r-nitrophenol phosphatek into each 5 ml of 13 substrate
buffer, and 50 ml of the developing solution was added to
each well. The plate was covered and allowed to incubate
for 30 min at room temperature. Plates were read on an
ELISA plate reader,l at a wavelength of 405 nm. In cases in
which the plate could not be read immediately, 50 ml of 3 N
NaOH was added to each well to stop the reaction. No
significant differences were found between plates read with
and without NaOH immediately after the incubation
period.
Data analysis
The output from the ELISA plate reader was analyzed
by using KC4 analysis software.m The following formula
was used to calculate percent inhibition: percent inhibition
5 100 2 [(A/B) 3 100], where A indicates the mean OD
value of test/positive/negative control serum, and B
indicates the OD value of no-serum control.
Determination of cutoff values
The cutoff values for the positive, negative, and suspect
ranges were determined by testing 15 serum samples from
confirmed culture-positive bottlenose dolphins (Tursiops
truncatus; Brucella spp. were isolated during clinical illness
or at necropsy). An additional 8 serum samples were tested
from confirmed culture-negative bottlenose dolphins. In
addition, by using the cutoff values determined from the
cetacean samples, serologic results obtained from the
following small group of pinniped species that were
determined to be culture positive at necropsy: Phoca
vitulina (n 5 3), Zalophus californianus (n 5 1), Callorhinus
ursinus (n 5 1), and Phoca groenlandica (n 5 1).
Test comparisons and cross reactivity
Serum samples from 48 wild common bottlenose
dolphins were tested in a blind study with the newly
developed cELISA, and results were compared with assays
that detect antibodies against B. abortus. The B. abortus
tests included Rivanol, Card, and buffered acidified plate
antigen test (BAPA) tests and were performed based on
protocols from the U.S. Department of Agriculture,
Animal and Plant Health Inspection Service, National
Veterinary Services Laboratories.n Dolphin serum samples
were collected during capture–release operations for health
assessments in Sarasota Bay, Florida (n 5 10),36 Indian
River Lagoon, Florida (n 5 17), and Charleston, South
Carolina (n 5 21),30 between June and August 2005. Serum
samples were also obtained from 28 wild Hawaiian monk
seals (Monachus schauinslandi) as part of an ongoing health
assessment study between 1998 and 2001 in the North-
western Hawaiian Islands. The samples were screened in a
blind study with the newly developed cELISA, and results
were compared with previously reported results that used
multiple B. abortus serologic assays, including BAPA,
indirect ELISA, fluorescence polarization assay, and
cELISA tests.26 Brucella abortus (n5 3), Brucella melitensis
(n5 2), and Yersinia enterocolitica 0:9 (Y09; n5 2) positive
sera were tested to evaluate cross-reactivity of terrestrial
Brucella antibodies with the cELISA.
Results
The serologic results for the culture-positive and
culture-negative bottlenose dolphins are shown in
Figure 1. Based on these results, the cutoff values for
the cELISA were determined as positive $30.0%,
suspect 25.0–29.9%, and negative #24.9%. In addi-
tion, by using the cutoff values determined from the
cetacean samples, serologic results obtained from a
small group of culture-positive pinnipeds are dis-
played (Fig. 2). Coefficient of variation (CV) for
intra-assay variability was determined by repeated
testing of 3 individual cetacean serum samples that
represented 3 levels of antigenic reactivity (strong
positive, positive, and negative), and the positive
control goat anti-Brucella plasma (Table 1). The CV
for interassay variability was determined by using the
previously described positive control and negative
control goat plasma (Table 2). Microbiologic culture
for Brucella was used as the criterion standard to
determine values of specificity and sensitivity for
cELISA testing in cetacean (Table 3) and pinniped
(Table 4) species, respectively. Brucella abortus–pos-
itive sera (n 5 3) also tested positive on the marine
cELISA, as did the B. melitensis–positive serum (n 5
2). Both of the Y09–positive sera (n 5 2) were
negative, which suggests no cross-reaction of these
antibodies with the harbor seal antigen.
Test comparison
Serologic comparison of the marine-origin cELISA
results with B. abortus test methods for the wild
bottlenose dolphin serum samples were performed.
The Card, BAPA, and Rivanol tests yielded a total of
19, 18, and 12 seropositive samples of 48, respectively.
A consensus method, previously used by others,7
requires that a sample must be positive on all tests to
858 Meegan et al.
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be considered a true positive. When this method is
applied, the number of (consensus) seropositive
samples decreased to 10 of 48. The marine-origin
cELISA detected 32 seropositive samples of 48 total
samples.
When Hawaiian monk seal serum samples were
tested by the marine-origin cELISA, the results
indicated that 16 of 28 samples were positive
(Fig. 3). The previously reported results from this
same set of samples revealed that 14 of 28 samples
were seropositive when B. abortus test methods were
applied.26 All of the samples that tested positive on
the B. abortus tests also tested positive with the
marine-origin cELISA. One of the 2 serum samples
that did not show agreement (Fig. 3; sample labeled
‘‘x’’) had inconsistent results with the B. abortus tests,
testing positive on all but one of the B. abortus test
methods. Although it this serum sample (labeled ‘‘x’’)
tested positive on 3 of 4 B. abortus tests, the consensus
method the authors applied required that this sample
be reported as seronegative.
Discussion
A cELISA that uses a whole-cell marine Brucella
sp. isolated from a harbor seal and designed for
screening marine mammal blood samples was suc-
cessfully developed. The cELISA is effective and
sensitive in detecting Brucella sp. antibodies for
pinniped and cetacean species, and further testing is
currently being performed to evaluate its utilization
for additional marine mammal species.
The CVs for both intra- and interassay variability
were less than 10% for positive samples. The CV for
both intra- and interassay testing for the negative
samples were relatively higher because of the lower
overall inhibition levels, but absolute standard
deviation for both tests were comparable with
positive samples. Overall, the CV values indicate that
the cELISA is both precise and consistent; the relative
increase in variation in the lower end of the testing
range emphasizes the importance of including a
suspect category for animals perhaps in need of
continued monitoring.
Specificity and sensitivity of the cELISA when
applied to cetacean sera revealed high sensitivity but
lower specificity. When used on pinniped sera, the
specificity and sensitivity were both reduced. Previous
reports have also demonstrated a lack of seroconver-
sion in pinniped species with confirmed Brucella sp.
infections.21,26,34 The data in the present study support
Figure 1. Percent inhibition results from 15 serum samples
of culture-positive bottlenose dolphins (Tursiops truncatus; black
bars), and 8 serum samples from culture-negative bottlenose
dolphins (gray bars) used in developing cutoff values. The negative
and positive control sera are also shown. The solid black line
demarcates the positive cutoff value: a positive result lies above the
line. The suspect range lies between the dashed and solid lines, and
a negative result below the dashed line.
Figure 2. Serologic results from culture-positive pinnipeds.
A positive test result lies above the solid line. The suspect range
lies between the dashed and solid lines, and a negative result below
the dashed line.
Table 1. Intra-assay variability for the competitive enzyme-
linked immunosorbent assay by using various test serum samples
and positive and negative control sera.
Positive
control
Strong
positive Positive Negative
No. of wells 84 84 84 84
No. of plates (runs) 28 28 28 28
Mean (% inhibition) 90.2 72.0 40.3 19.6
Standard deviation 1.3 2.6 3.2 2.3
Coefficient of
variation (%) 1.4 3.5 8.0 11.9
Table 2. Interassay variability for the competitive enzyme-
linked immunosorbent assay by using positive and negative
control sera.
Positive control Negative control
No. of wells 147 147
No. of plates (runs) 49 49
Mean (% inhibition) 88.1 16.1
Standard deviation 2.1 4.0
Coefficient of variation (%) 2.3 24.9
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these previously reported findings, which may explain
the lower sensitivity. In addition, it has been reported
that Brucella sp. are often isolated from tissues of
pinnipeds without corresponding significant associ-
ated gross or histopathologic lesions.11
Recently, it has been suggested that different
marine Brucella isolates have varying degrees of
pathogenicity based on their genetic structure (Ma-
quart M, Zygmunt MS, Cloeckaert A: 2008, Marine
mammal Brucella isolates with different genomic
backgrounds display a differential response to human
macrophage infection. Brucellosis International Re-
search Conference, Egham, Surrey, England). Alter-
natively, each marine mammal species being surveyed
may respond to the bacteria in different immunologic
ways, depending on the location and severity of
infection, pathogenesis, and individual immune re-
sponses.
Ideally, validation data and analysis should be
performed on each marine mammal species that is
evaluated. However, because of limited sample sizes
of confirmed Brucella-positive control blood samples
for each species examined, combined with legal,
logistical, and ethical problems associated with
producing laboratory populations of marine mam-
mals infected with this zoonotic pathogen, it becomes
extremely difficult to use these indices of validation
with confidence.26 It is important to note that, in the
current study, the number of serum samples paired
with successful microbiologic isolates was low and
not ideal for determining statistical data. Therefore,
until more information is obtained regarding species
variations with infection and antibody production,
sensitivity and specificity information is limited and
difficult to interpret.
The cELISA described in the present study uses a
whole-cell Brucella antigen, which is in contrast to
using isolated cell wall components, specifically the
LPS portion often used for terrestrial Brucella
serologic methods.25 A recently developed indirect
ELISA was designed16 specifically for testing odon-
tocete serum. This indirect ELISA uses LPS as the
antigen; however, it uses terrestrial B. abortus and B.
melitensis LPS rather than marine-origin LPS as the
antigen. Further investigation is warranted to evalu-
ate utilization of various cell wall components as
antigens.
Utilization of a whole-cell antigen–based assay may
be useful because certain outer membrane proteins
specific for determining the antigenic nature of
terrestrial Brucella to its host have also been identified
in marine mammal strains.4,5,35 The genes omp2a/b,
omp25, omp28, and omp31 have been identified from
various cetacean and pinniped isolates, and diver-
gence in protein expression has been described within
marine mammal strains when compared with terres-
trial strains.3–5,35 These antigenic outer membrane
proteins may be unique to marine mammal Brucella
biovars and useful for antibody detection assays.
The use of a polyclonal antibody combined with a
whole-cell antigen may increase sensitivity at the cost
of specificity, with a risk of an increase in the number
of false-positive results occurring through nonspecific
binding with antibodies present in the test sera against
similar Gram-negative organisms. However, more
cross-reactivity can occur when IgM is measured;
therefore, the use of an IgG, as in this assay, is ideal.25
Table 3. Specificity and sensitivity determined with cetacean
serum samples.
Competitive enzyme-linked
immunosorbent assay
Culture
Total+ 2
+ 6 16 22
2 0 44 28
Total 6 60 50
Sensitivity (%) 100
Specificity (%) 73
Table 4. Specificity and sensitivity determined with pinniped
serum samples.
Competitive enzyme-linked
immunosorbent assay
Culture
Total+ 2
+ 4 26 30
2 2 88 90
Total 6 114 120
Sensitivity (%) 67
Specificity (%) 77
Figure 3. Serologic results from Hawaiian monk seal
(Monachus schauinslandi) serum samples obtained from the
marine-origin competitive enzyme-linked immunosorbent assay
(cELISA). Positive values are indicated above the solid line. The
suspect range lies between the dashed and solid lines, and a
negative result lies below the dashed line. The samples labeled with
a ‘‘+’’ sign and an ‘‘x’’ sign indicate serum samples that tested
positive with the cELISA but negative with the terrestrial
test methods.
860 Meegan et al.
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Previous studies have noted cross-reactivity of Y09
with B. abortus serologic tests because of common
antigenic epitopes of the smooth LPS O chain
between these species.13,19,24 Although marine mam-
mal infection with Y09 has not yet been reported, and
a previous study did not detect Y09 antibodies in
serum from various marine mammals,33 the potential
for transmission theoretically exists. Knowledge of
potential cross-reaction of the marine cELISA with
Y09 antibodies will help differentiate between these
pathogens. Although only two Y09-positive serum
samples were available for testing, these samples
tested negative on the marine cELISA, which suggests
that cross-reaction is absent. In addition, B. abortus–
and B. melitensis–positive serum tested positive on the
marine cELISA, which confirmed cross-reaction of
these Brucella spp. with the marine antigen.
Overall, the comparison testing performed in the
current study reveals that the marine-origin cELISA
is a more sensitive assay than the classic B. abortus
methods for detecting anti-Brucella antibodies in both
cetacean and pinniped species. Despite this higher
sensitivity, the cutoff ranges for the newly developed
cELISA were determined conservatively (Fig. 1).
More importantly, the classic B. abortus tests failed
to detect a seropositive result, but the marine-origin
cELISA confirmed the presence of antibodies.21,22
Results of testing showed that use of the current
cELISA compared favorably with results obtained
from multiple terrestrial Brucella sp. tests and
indicates that this assay can be used successfully in
lieu of multiple assay consensus testing in a variety of
marine mammal species. The newly developed ma-
rine-origin cELISA is a reliable, rapid screening assay
capable of evaluating multiple samples per plate and
makes it useful for health screenings and as a
diagnostic tool for clinical case situations.
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Sources and manufacturers
a. 103 PBS stock (pH 7.2, product 71003-073), Invitrogen
Corp., Carlsbad, CA.
b. DNeasyH Tissue Kit, Qiagen Inc., Valencia, CA.
c. Antibody Production Project PAB-105-1413A, Rockland
Immunochemicals Inc., Gilbertsville, PA.
d. EZ-LinkH Sulfo-NHS-Biotin kit (product 21335), Pierce
Biotechnology Inc., Rockford, IL.
e. Slide-A-LyzerH Dialysis Cassettes (product 66807), Pierce
Biotechnology Inc., Rockford, IL.
f. Nunc-ImmunoTM MaxiSorp 96-well plates (product 442404),
Thermo Fisher Scientific Inc., Waltham, MA.
g. ELx405TM Select, BioTek Instruments Inc., Winooski, VT.
h. Bovine Serum Albumin (product A7030), Sigma-Aldrich, St.
Louis, MO.
i. ExtraAvidinH-labeled Alkaline Phosphatase (product E2636),
Sigma-Aldrich, St. Louis, MO.
j. Diethanolamine Substrate Buffer 53 (product 34064), Pierce
Biotechnology Inc., Rockford, IL.
k. r-nitrophenyl phosphate 5 mg tablets (product S0942), Sigma-
Aldrich, St. Louis, MO.
l. EL800TM Universal Microplate Reader, BioTek Instruments
Inc., Winooski, VT.
m. Kineticalc for Windows NT 5.0 version 2.6, BioTek Instru-
ments Inc., Winooski, VT.
n. Buffered acidified plate antigen test for detection of antibodies
to Brucella abortus. SOP #: SEROPRO1024.02, effective date:
March 1, 2004; Rivanol precipitation plate agglutination test
for detection of antibodies to Brucella abortus. SOP:
SEROPRO1025.03, effective date: April 29, 2004; Card test
for detection of antibodies to Brucella abortus. SOP:
SEROPRO1027.02, effective date: February 19, 2003.
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